Literature DB >> 14329961

THE IDENTIFICATION OF ATYPICAL STRAINS OF PSEUDOMONAS AERUGINOSA.

A H WAHBA, J H DARRELL.   

Abstract

Entities:  

Keywords:  CLASSIFICATION; CULTURE MEDIA; EXPERIMENTAL LAB STUDY; METABOLISM; PEPTIDE HYDROLASES; PIGMENTS; PSEUDOMONAS AERUGINOSA

Mesh：

Substances：

Year:  1965        PMID： 14329961     DOI： 10.1099/00221287-38-3-329

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN： 0022-1287


× No keyword cloud information.
  34 in total

1.  An outbreak of Pseudomonas aeruginosa (pyocyanea) infection in a Premature Baby Unit, with observations on the intestinal carriage of Pseudomonas aeruginosa in the newborn.

Authors:  C H Jellard; G M Churcher
Journal:  J Hyg (Lond)       Date:  1967-06

2.  Clinical characteristics associated with isolation of small-colony variants of Staphylococcus aureus and Pseudomonas aeruginosa from respiratory secretions of patients with cystic fibrosis.

Authors:  Michael Schneider; Kathrin Mühlemann; Sara Droz; Sabine Couzinet; Carmen Casaulta; Stefan Zimmerli
Journal:  J Clin Microbiol       Date:  2008-03-05       Impact factor: 5.948

3.  Conversion of Pseudomonas aeruginosa to the phenotype characteristic of strains from patients with cystic fibrosis.

Authors:  D P Speert; S W Farmer; M E Campbell; J M Musser; R K Selander; S Kuo
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

Review 4.  Pyocyanin: production, applications, challenges and new insights.

Authors:  Sheeba Jayaseelan; Damotharan Ramaswamy; Selvakumar Dharmaraj
Journal:  World J Microbiol Biotechnol       Date:  2013-11-09       Impact factor: 3.312

5.  Genetic diversity of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis revealed by restriction fragment length polymorphism of the rRNA gene region.

Authors:  C Martin; M A Ichou; P Massicot; A Goudeau; R Quentin
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

6.  Selective media for isolation of Burkholderia (Pseudomonas) cepacia from the respiratory secretions of patients with cystic fibrosis.

Authors:  N Cimolai; C Trombley; A G Davidson; L T Wong
Journal:  J Clin Pathol       Date:  1995-05       Impact factor: 3.411

7.  In vitro evaluation of tobramycin and aztreonam versus Pseudomonas aeruginosa biofilms on cystic fibrosis-derived human airway epithelial cells.

Authors:  Qianru Yu; Edward F Griffin; Sophie Moreau-Marquis; Joseph D Schwartzman; Bruce A Stanton; George A O'Toole
Journal:  J Antimicrob Chemother       Date:  2012-07-26       Impact factor: 5.790

8.  Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis.

Authors:  E Mahenthiralingam; M E Campbell; D P Speert
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

9.  Diagnostic criteria for differentiation of pseudomonads pathogenic for man.

Authors:  G L Gilardi
Journal:  Appl Microbiol       Date:  1968-10

10.  Parallel evolution in Pseudomonas aeruginosa over 39,000 generations in vivo.

Authors:  Holly K Huse; Taejoon Kwon; James E A Zlosnik; David P Speert; Edward M Marcotte; Marvin Whiteley
Journal:  MBio       Date:  2010-09-21       Impact factor: 7.867
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.